BRIEF COMMUNICATION


Acesso aberto Revisado por pares

6808

Visualizações

Increased BDNF levels in long-term bipolar disorder patients

Increased BDNF levels in long-term bipolar disorder patients

Izabela Guimaraes Barbosa1,2, Natália Pessoa Rocha2, Aline Silva de Miranda2, Rodrigo Barreto Huguet1, Moisés Evandro Bauer3, Helton José Reis1, Antônio Lúcio Teixeira1,2

Vol.35 Issue 1/2013: 67-69

ABSTRACT

INTRODUCTION: Bipolar disorder (BD) is a prevalent, chronic and progressive illness. There is a growing body of evidence indicating that brain-derived neurotrophic factor (BDNF) plays an important role in the pathophysiology of BD.
OBJECTIVE: The aim of this study was to evaluate BDNF plasma levels in BD patients with long term illness in comparison with controls.
METHODS: 87 BD type I patients and 58 controls matched by age, gender and education level were enrolled in this study. All subjects were assessed by the Mini-International Neuropsychiatric Interview and the patients by the Young Mania Rating Scale and the Hamilton Depression Rating Scale. The plasma levels of BDNF were measured by ELISA.
RESULTS: On average, patients had suffered from BD for 23.4 years. In comparison with controls, BD patients with mania presented a 1.90-fold increase in BDNF plasma levels (p = .001), while BD patients in remission presented a 1.64-fold increase in BDNF plasma levels (p = .03). BDNF plasma levels were not influenced by age, length of illness or current medications.
CONCLUSIONS: The present study suggests that long-term BD patients exhibit increased circulating levels of BDNF.

Keywords: Bipolar Disorder; BDNF; Mania; Neurotrophic Factor; Pathophysiology.


THE CONTENT OF THIS ARTICLE IS NOT AVAILABLE FOR THIS LANGUAGE.


© 2026 All rights reserved